Andrea R Hagemann
Washington University School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Andrea R Hagemann as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:21 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05903131 · Uterine Preservation Via Lifestyle TransformationWashington University School of Medicine · recruiting · Endometrial Hyperplasia, Grade 1 Endometrial Cancer · principal investigator
- Ph2NCT05829460 · Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial HyperplasiaWashington University School of Medicine · withdrawn · Endometrial Hyperplasia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:21 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Project 3: Primary Prevention and Uterine Preservation in Premenopausal Women with Obesity and Endometrial Hyperplasia/CancerP50CA265793 · NCI · WASHINGTON UNIVERSITY · fiscal years 2023 to 2026 · $212,525 awarded in 2026Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:21 UTC. The ranking covers the 200 most relevant of 14 PubMed records, and a shared surname and initials can bring in a namesake. All 14 on PubMed
- Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.N Engl J Med · 2019733 citationsRCR 27.1
- Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study.J Clin Oncol · 2020301 citationsRCR 11.9
- A prospective, randomized, double-blinded study of assisted hatching in women younger than 38 years undergoing in vitro fertilization.Fertil Steril · 201029 citationsRCR 1.2
- 24 citationsRCR 6.0
- Phase II study of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer.Gynecol Oncol · 201322 citationsRCR 0.6
- Wound Complication Rates After Staples or Suture for Midline Vertical Skin Closure in Obese Women: A Randomized Controlled Trial.Obstet Gynecol · 201721 citationsRCR 1.3
- Text-message-based behavioral weight loss for endometrial cancer survivors with obesity: A randomized controlled trial.Gynecol Oncol · 202119 citationsRCR 1.3
- 17 citationsRCR 0.6
- A phase II trial of a surgical protocol to decrease the incidence of wound complications in obese gynecologic oncology patients.Gynecol Oncol · 201415 citationsRCR 0.7
- 12 citationsRCR 2.6